共 17 条
[1]
Biochemical detection of left-ventricular systolic dysfunction. McDonagh TA,Robb SD,Murdoch DR,et al. The Lancet . 1998
[2]
BNP: pathophysiological and potential therapeutic roles in acute congestive heart failure. Grantham JA,Borgeson DD,Burnett JC Jr. American Journal of Physiology . 1997
[3]
Plasma brain natriuretic peptide in assessment of acute dyspnea. Davis M,Espiner E,Richards G,et al. The Lancet . 1994
[4]
Value of plasma B-type natriuretic peptide measurement for heart disease screening in a Japanese population. Nakamura M,Endo H,Nasu M,et al. Heart . 2002
[5]
B-type natriuretic peptide (BNP) predicts future cardiac events in patients presenting to the emergency department with dyspnea. Harrison A,Morrison LK,Krishnaswamy P,et al. Annals of Emergency Medicine . 2002
[6]
Rapid measurement of Btype natriuretic peptide in the emergency diagnosis of heart failure. Maisel AS,Krishnaswamy P,Nowak RM,et al. The New England Journal of Medicine . 2002
[7]
B-type natriuretic peptide predicts sudden death in patients with chronic heart failure. Berger R,Huelsman M,Strecker K,et al. Circulation . 2002
[8]
B-type natriuretic peptide in the diagnosis and management of congestive heart failure. Maisel A. Cardiology Clinics . 2001
[9]
B- type natriuretic peptide levels: diagnostic and prognostic in congestive heart failure: what’s next. Maisel A. Circulation . 2002
[10]
Effects of valsartan on circulating brain natriuretic peptide and norepinephrine in symptomatic chronic heart failure:the Valsartan Heart Failure Trial (Val - HeFT). Latini R,Masson S,Anand I,et al. Circulation . 2002